Mustafa Munye

Director R&D Operations • Complement Therapeutics

Mustafa Munye, Ph.D has 10+ years in the discovery and development of ATMP’s. He has led process and analytical development for AAV gene therapies, CAR-T and PSC-derived cell therapies to support first-in-human studies. Mustafa is currently director of R&D Operations at Complement Therapeutics whose lead program is an AAV gene therapy.

Also speaking

Kinnari Patel

Chief Operating Officer • Rocket Pharma

23 May 2022

Sven Kili

Chief Executive Officer • Antion

20 May 2022

Joel Eichmann

Co-Founder • Green Elephant Biotech

23 May 2022

Event Info

Sponsorship Brochure

Take a look at the 2023 sponsorship opportunities here.

6 March 2023

Agenda at a Glance

Check out the Agenda at a Glance for Advanced Therapies Europe 2023.

1 February 2023

Company

Resources

Network

Twitter

Clarion Events Limited is registered in England and Wales, Company Number 00454826, VAT No. GB 843845601 Registered Office: Bedford House, 69-79 Fulham High Street, London, SW6 3JW, United Kingdom.

This site uses cookies which are essential to make the site function effectively. By using our site you accept the terms of our cookie policy. Find out more.